title: Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
authors.affiliation: Medical School, University of Kerman, Iran. h.daneshvar@bio.gla.ac.uk
authors.forename: H
authors.initials: H
authors.lastname: Daneshvar
authors.forename: M M
authors.initials: MM
authors.lastname: Molaei
authors.forename: H
authors.initials: H
authors.lastname: Kamiabi
authors.forename: R
authors.initials: R
authors.lastname: Burchmore
authors.forename: P
authors.initials: P
authors.lastname: Hagan
authors.forename: R
authors.initials: R
authors.lastname: Stephen Phillips
mesh_terms: D000825:Animal Structures / Q000469:parasitology; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000378:metabolism*; D004283:Dog Diseases / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D004285:Dogs; D005260:Female; D005839:Gentamicins / Q000378:metabolism*; D007111:Immunity, Cellular; D007074:Immunoglobulin G / Q000097:blood; D007271:Injections, Intradermal; D007371:Interferon-gamma / Q000378:metabolism; D016753:Interleukin-10 / Q000378:metabolism; D018314:Leishmania infantum / Q000187:drug effects* / Q000276:immunology; D007898:Leishmaniasis, Visceral / Q000276:immunology / Q000473:pathology / Q000517:prevention & control / Q000662:veterinary*; D008297:Male; D016052:Protozoan Vaccines / Q000008:administration & dosage / Q000276:immunology*; D013997:Time Factors; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D005839:Gentamicins; D007074:Immunoglobulin G; D016052:Protozoan Vaccines; D014613:Vaccines, Attenuated; D016753:Interleukin-10; D007371:Interferon-gamma